Form D · Biotechnology
SiNON Therapeutics
Durham, NC · CIK 0001827094
Offering snapshot reported Oct 13, 2020 · SEC filing
- Reported sold
- $0 Offering amount: $169K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Oct 1, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 13, 2020 | Initial | $0 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-377770
SAFE Agreement. Total raised $168,500
SAFE Agreement
Source: Form D, filed Oct 13, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Afreen Allam | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
321 Olive Branch Road
Durham, NC, 27703
Durham, NC, 27703